Johnson & Johnson (JNJ) EPS (Basic) (2009 - 2026)

Johnson & Johnson (JNJ) has 17 years of EPS (Basic) data on file, last reported at $2.17 in Q1 2026.

• Quarterly EPS (Basic) fell 52.43% year-over-year to $2.17 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.74 (up 91.17% YoY) and the FY2023 annual result came in at $8.62, up 1339.66% from the prior year.
• EPS (Basic) rose to $2.17 in Q1 2026 per JNJ's latest filing, from $2.13 in the prior quarter.
• The five-year high for EPS (Basic) was $8.61 in Q4 2023, with the low at -$0.09 in Q3 2023.
• Average EPS (Basic) over 4 years is $1.73, with a median of $0.22 recorded in 2022.
• The widest YoY moves for EPS (Basic): up 15185.76% in 2023, down 142.53% in 2023.
• Johnson & Johnson's EPS (Basic) stood at $0.06 in 2022, then sank by 158.17% to -$0.03 in 2023, then jumped by 6586.72% to $2.13 in 2025, then grew by 2.27% to $2.17 in 2026.
• Business Quant data shows JNJ's EPS (Basic) at $2.17 in Q1 2026, $2.13 in Q4 2025, and $2.14 in Q3 2025.